Yu J. Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Heterogeneity in plasma p-tau217 response and its association with cognitive trajectories under lecanemab treatment.

Heterogeneity in plasma p-tau217 response and its association with cognitive trajectories under lecanemab treatment.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 22, 2026

Association of plasma irisin levels with amyloid burden in the Alzheimer's disease spectrum.

Association of plasma irisin levels with amyloid burden in the Alzheimer's disease spectrum.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: April 13, 2026

Real-world implementation of lecanemab in Korean patients at a tertiary memory clinic: Safety, ARIA risk, and early treatment patterns.

Real-world implementation of lecanemab in Korean patients at a tertiary memory clinic: Safety, ARIA risk, and early treatment patterns.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: April 09, 2026

Impact of appendicular skeletal muscle mass on Alzheimer's disease in relation to age and comorbidities: an 8-year longitudinal follow-up study of a nationwide cohort.

Impact of appendicular skeletal muscle mass on Alzheimer's disease in relation to age and comorbidities: an 8-year longitudinal follow-up study of a nationwide cohort.

Journal: Alzheimer's research & therapy

Published: December 30, 2025

Feasibility and Preliminary Efficacy of Digital Cognitive Training in Parkinson's Disease With Mild Cognitive Impairment: A Pilot Study.

Feasibility and Preliminary Efficacy of Digital Cognitive Training in Parkinson's Disease With Mild Cognitive Impairment: A Pilot Study.

Journal: Journal of movement disorders

Published: May 19, 2025

Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson's disease: a 12-year longitudinal study.

Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson's disease: a 12-year longitudinal study.

Journal: Frontiers in aging neuroscience

Published: May 19, 2025

Twelve-year nationwide cohort study identifying risk factors for conversion from mild cognitive impairment to Alzheimer's disease.

Twelve-year nationwide cohort study identifying risk factors for conversion from mild cognitive impairment to Alzheimer's disease.

Journal: Scientific reports

Published: November 24, 2024

Impact of sleep apnea on alzheimer's disease in relation to sex: an 8-year longitudinal follow-up study of a nationwide cohort.

Impact of sleep apnea on alzheimer's disease in relation to sex: an 8-year longitudinal follow-up study of a nationwide cohort.

Journal: Alzheimer's research & therapy

Published: September 05, 2024

Sarcopenia is a predictor for Alzheimer's continuum and related clinical outcomes.

Sarcopenia is a predictor for Alzheimer's continuum and related clinical outcomes.

Journal: Scientific reports

Published: February 29, 2024

Effect of Tablet-based Cognitive Intervention on Cognition in Patients With Mild Cognitive Impairment: A Pilot Study.

Effect of Tablet-based Cognitive Intervention on Cognition in Patients With Mild Cognitive Impairment: A Pilot Study.

Journal: Dementia and neurocognitive disorders

Published: July 09, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026